The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures
Crossref DOI link: https://doi.org/10.1186/s12885-016-2501-0
Published Online: 2016-07-28
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cockburn, Jessica G.
Hallett, Robin M.
Gillgrass, Amy E.
Dias, Kay N.
Whelan, T.
Levine, M. N.
Hassell, John A.
Bane, Anita
License valid from 2016-07-28